|drug464||Best Practice Wiki||0.45|
|D007676||Kidney Failure, Chronic NIH||0.38|
|D003324||Coronary Artery Disease NIH||0.38|
|D029424||Pulmonary Disease, Chronic Obstructive NIH||0.29|
There is one clinical trial.
This study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared for sensitivity, specificity, positive predictive value and negative predictive value.
Description: Comparison of accuracy, sensitivity, specificity, and positive and negative predictive values between the two assays.Measure: Test characteristics Time: 3 months
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports